INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
The DOI matches its Crossref record; 523 of the 536 references it cites were found in a registry or an index.
Abstract
In Brief Background: Intravitreal injection (IVI) with administration of various pharmacological agents is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related macular degeneration, cystoid macular edema, diabetic retinopathy, uveitis, vascular occlusions, and retinal detachment. The indications and therapeutic agents are reviewed in this study. Methods: A search of the English, German, and Spanish language MEDLINE database was conducted. A total of 654 references spanning the period through early 2008 were individually evaluated. Results: The advantage of the IVI technique is the ability to maximize intraocular levels of medications and to avoid the toxicities associated with systemic treatment. Intravitreal injection has been used to deliver several types of pharmacological agents into the vitreous cavity: antiinfective and antiinflammatory medications, immunomodulators, anticancer agents, gas, antivascular endothelial growth factor, and several others. The goal of this review is to provide a detailed description of the properties of numerous therapeutic agents that can be delivered through IVI, potential complications of the technique, and recommendations to avoid side effects. Conclusion: The IVI technique is a valuable tool that can be tailored to the disease process of interest based on the pharmacological agent selected. This review provides the reader with a comprehensive summary of the IVI technique and its multitude of uses. Intravitreal injection has been used to deliver numerous pharmacological agents into the vitreous cavity: antiinfective and antiinflammatory medications, immunomodulators, antineoplastic agents, gas, antivascular endothelial growth factor, and others. In this review, we describe the properties of many intravitreal therapeutic agents, the technique of intravitreal injection, complications, recommendations to avoid side effects, and future trends.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although rates of intraocular inflammation related to intravitreal injection remain relatively low, the overall burden on patients remains a key concern with millions of injections performed every year [85].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [85]
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Effects of cytochalasin and phalloidin on actin.
Cooper, J. A. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.4.1473 · Cited by 2,009
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Avery, R. L., Pieramici, D. J., Rabena, M. D., Castellarin, A. A., Nasir, M. A., & Giust, M. J. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.11.019 · Cited by 1,133
Role of vascular endothelial growth factor in regulation of physiological angiogenesis
Ferrara, N. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.6.c1358 · Cited by 1,085
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Ferrara, N., Hillan, K. J., & Novotny, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.132 · Cited by 977
Fung, A. E., Lalwani, G. A., Rosenfeld, P. J., Dubovy, S. R., Michels, S., Feuer, W. J., Puliafito, C. A., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.028 · Cited by 972
Antiviral drugs in current clinical use
De Clercq, E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.02.009 · Cited by 947
SEHGAL, S. N., BAKER, H., & VÉZINA, C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.727 · Cited by 947
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Management of Diabetic Retinopathy: A Systematic Review
Mohamed, Q., Gillies, M. C., & Wong, T. Y. (2007) · JAMA · doi:10.1001/jama.298.8.902 · Cited by 891
Regillo, C. D., Brown, D. M., Abraham, P., Yue, H., Ianchulev, T., Schneider, S., & Shams, N. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.10.004 · Cited by 858
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor
Faktorovich, E. G., Steinberg, R. H., Yasumura, D., Matthes, M. T., & LaVail, M. M. (1990) · Nature · doi:10.1038/347083a0 · Cited by 710
Spectrum and Susceptibilities of Microbiologic Isolates in the Endophthalmitis Vitrectomy Study
HAN, D. P., WISNIEWSKI, S. R., WILSON, L. A., BARZA, M., VINE, A. K., DOFT, B. H., KELSEY, S. F., & THE ENDOPHTHALMITIS VITRECTOMY STUDY GROUP (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71959-2 · Cited by 702
MICHELS, S., ROSENFELD, P., PULIAFITO, C., MARCUS, E., & VENKATRAMAN, A. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.02.007 · Cited by 664
Sehgal, S. N. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00045-9 · Cited by 663
SPAIDE, R. F., LAUD, K., FINE, H. F., KLANCNIK, J. M., MEYERLE, C. B., YANNUZZI, L. A., SORENSON, J., SLAKTER, J., FISHER, Y. L., & COONEY, M. J. (2006) · Retina · doi:10.1097/00006982-200604000-00001 · Cited by 630
Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus
De Clercq, E., Descamps, J., Verhelst, G., Walker, R. T., Jones, A. S., Torrence, P. F., & Shugar, D. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.5.563 · Cited by 604
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 590
VEGF as a Therapeutic Target in Cancer
Ferrara, N. (2005) · Oncology · doi:10.1159/000088479 · Cited by 578
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004) · Retina · doi:10.1097/00006982-200410000-00002 · Cited by 572
Beer, P. M., Bakri, S. J., Singh, R. J., Liu, W., Peters, G. B., & Miller, M. (2003) · Ophthalmology · doi:10.1016/s0161-6420(02)01969-3 · Cited by 570
(2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.015 · Cited by 548
Fung, A. E., Rosenfeld, P. J., & Reichel, E. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.099598 · Cited by 532
The quinolones: decades of development and use
Emmerson, A. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg208 · Cited by 531
Intravitreal triamcinolone acetonide for exudative age related macular degeneration
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.462 · Cited by 492
Rosenfeld, P. J., Fung, A. E., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-15 · Cited by 489
A New Class of Steroids Inhibits Angiogenesis in the Presence of Heparin or a Heparin Fragment
Crum, R., Szabo, S., & Folkman, J. (1985) · Science · doi:10.1126/science.2416056 · Cited by 488
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study
Antcliff, R. J., Spalton, D. J., Stanford, M. R., Graham, E. M., ffytche, T. J., & Marshall, J. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00658-8 · Cited by 487
Reich, S. J., Fosnot, J., Kuroki, A. M., Tang, W., Yang, X., Maguire, A. M., Bennett, J., & Tolentino, M. J. (2003) · PubMed · Cited by 486
RICH, R. M., ROSENFELD, P. J., PULIAFITO, C. A., DUBOVY, S. R., DAVIS, J. L., FLYNN, H. W., GONZALEZ, S., FEUER, W. J., LIN, R. C., LALWANI, G. A., et al. (2006) · Retina · doi:10.1097/01.iae.0000225766.75009.3a · Cited by 484
Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema
Jonas, J. B., & Söfker, A. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01010-8 · Cited by 481
Antiviral drugs for cytomegalovirus diseases
Biron, K. K. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.002 · Cited by 468
ITURRALDE, D., SPAIDE, R. F., MEYERLE, C. B., KLANCNIK, J. M., YANNUZZI, L. A., FISHER, Y. L., SORENSON, J., SLAKTER, J. S., FREUND, K. B., COONEY, M., et al. (2006) · Retina · doi:10.1097/00006982-200603000-00005 · Cited by 460
Collagen: Molecular Diversity in the Body's Protein Scaffold
Eyre, D. R. (1980) · Science · doi:10.1126/science.7355290 · Cited by 451
Straus, S. K., & Hancock, R. E. W. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.009 · Cited by 446
INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
DANIS, R. P., CIULLA, T. A., & PRATT, W. A. (2000) · Retina · doi:10.1097/00006982-200003000-00004 · Cited by 423
Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.1.24 · Cited by 422
THE EYETECH STUDY GROUP (2002) · Retina · doi:10.1097/00006982-200204000-00002 · Cited by 415
Virus interference. II. Some properties of interferon
Isaacs, A., Lindenmann, J., & Valentine, R. C. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0049 · Cited by 413
Emerging fluoroquinolone resistance in bacterial keratitis
Goldstein, M. H., Kowalski, R. P., & Gordon, Y. J. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)00716-2 · Cited by 408
Acute endophthalmitis following intravitreal triamcinolone acetonide injection
Moshfeghi, D. M., Kaiser, P. K., Scott, I. U., Sears, J. E., Benz, M., Sinesterra, J. P., Kaiser, R. S., Bakri, S. J., Maturi, R. K., Belmont, J., et al. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00483-5 · Cited by 397
Self-citationVitamin C Function and Status in Chronic Disease
Jacob, R. A., & Sotoudeh, G. (2002) · Nutrition in Clinical Care · doi:10.1046/j.1523-5408.2002.00005.x · Cited by 392
Predicted biological activity of intravitreal VEGF Trap
Stewart, M. W., & Rosenfeld, P. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.134874 · Cited by 375
Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion
Greenberg, P. B. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.2.247 · Cited by 370
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Heier, J. S., Antoszyk, A. N., Pavan, P. R., Leff, S. R., Rosenfeld, P. J., Ciulla, T. A., Dreyer, R. F., Gentile, R. C., Sy, J. P., Hantsbarger, G., et al. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.052 · Cited by 360
Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases
Benz, M. S., Scott, I. U., Flynn, H. W., Unonius, N., & Miller, D. (2004) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00896-1 · Cited by 358
Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis
Young, S., Larkin, G., Branley, M., & Lightman, S. (2001) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2001.00360.x · Cited by 352
Mordenti, J., Cuthbertson, R. A., Ferrara, N., Thomsen, K., Berleau, L., Licko, V., Allen, P. C., Valverde, C. R., Meng, Y. G., Fei, D. T. W., et al. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700507 · Cited by 350
Ohno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Sugita, S., Ueno, S., Yoshizaki, K., & 稲葉, 午. (2004) · PubMed · Cited by 343
Martin, D. F. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090240037023 · Cited by 338
Treatment of Intraocular Proliferation with Intravitreal Injection of Triamcinolone Acetonide
Tano, Y., Chandler, D., & Machemer, R. (1980) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75196-7 · Cited by 338
Palestine, A. G., Polis, M. A., De Smet, M. D., Baird, B. F., Falloon, J., Kovacs, J. A., Davey, R. T., Zurlo, J. J., Zunich, K. M., Davis, M., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-665 · Cited by 327
Nussenblatt, R. B., Palestine, A. G., & Chan, C.-C. (1983) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)77814-6 · Cited by 323
Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection
JONAS, J., DEGENRING, R., KREISSIG, I., AKKOYUN, I., & KAMPPETER, B. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.10.042 · Cited by 323
Hilton, G. F., & Grizzard, W. S. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33696-0 · Cited by 322
Treatment of Chronic Macular Edema With Acetazolamide
Cox, S. N., Hay, E., & Bird, A. C. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060140350030 · Cited by 320
Fungal and Parasitic Infections of the Eye
Klotz, S. A., Penn, C. C., Negvesky, G. J., & Butrus, S. I. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.662 · Cited by 309
Smith, J. A., Thompson, D. J. S., Whitcup, S. M., Suhler, E., Clarke, G., Smith, S., Robinson, M., Kim, J., & Barron, K. S. (2005) · Arthritis Care & Research · doi:10.1002/art.20904 · Cited by 308
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
Shen, J., Samul, R., Silva, R. L., Akiyama, H., Liu, H., Saishin, Y., Hackett, S. F., Zinnen, S., Kossen, K., Fosnaugh, K., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302641 · Cited by 307
Suhler, E. B. (2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.7.903 · Cited by 306
TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)
MANZANO, R. P. A., PEYMAN, G. A., KHAN, P., & KIVILCIM, M. (2006) · Retina · doi:10.1097/00006982-200603000-00001 · Cited by 305
Self-citationAge-related changes in human vitreous structure
Sebag, J. (1987) · Graefes Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02160337 · Cited by 303
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/j.ohc.2006.05.009 · Cited by 299
Gillies, M. C. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.5.667 · Cited by 298
Etanercept therapy in children with treatment-resistant uveitis
Reiff, A., Takei, S., Sadeghi, S., Stout, A., Shaham, B., Bernstein, B., Gallagher, K., & Stout, T. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1411::aid-art235>3.0.co;2-o · Cited by 298
Intravitreal triamcinolone acetonide and intraocular pressure
Smithen, L. M., Ober, M. D., Maranan, L., & Spaide, R. F. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.06.067 · Cited by 296
Statewide Study of Chloramphenicol Therapy and Fatal Aplastic Anemia
Wallerstein, R. O. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03160110017004 · Cited by 285
Smith, J. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01125-9 · Cited by 277
Baley, J. E., Kliegman, R. M., & Fanaroff, A. A. (1984) · Pediatrics · doi:10.1542/peds.73.2.144 · Cited by 275
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience
Frenkel, S., Hendler, K., Siegal, T., Shalom, E., & Pe'er, J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.127928 · Cited by 271
Liposomes—A selective drug delivery system for the topical route of administration: gel dosage form
Mezei, M., & Gulasekharam, V. (1982) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1982.tb04767.x · Cited by 268
Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis
Essman, T. F., Flynn, H. W., Smiddy, W. E., Brod, R. D., Murray, T. G., Davis, J. L., & Rubsamen, P. E. (1997) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-19970301-03 · Cited by 264
Marangon, F. B., Miller, D., Giaconi, J. A., & Alfonso, E. C. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.078 · Cited by 264
SDF-1 is both necessary and sufficient to promote proliferative retinopathy
Butler, J. M., Guthrie, S. M., Koc, M., Afzal, A., Caballero, S., Brooks, H. L., Mames, R. N., Segal, M. S., Grant, M. B., & Scott, E. W. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522869 · Cited by 263
The Lack of Toxicity of Intravitreally Administered Triamcinolone Acetonide
McCuen, B. W., Bessler, M., Tano, Y., Chandler, D., & Machemer, R. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90013-1 · Cited by 262
NELSON, M. L., TENNANT, M. T. S., SIVALINGAM, A., REGILLO, C. D., BELMONT, J. B., & MARTIDIS, A. (2003) · RETINA · doi:10.1097/00006982-200310000-00014 · Cited by 256
Edelman, J. L., Lutz, D., & Castro, M. R. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.09.013 · Cited by 246
Intravitreal triamcinolone and elevated intraocular pressure
Fracs, R. J. B. W., & Fracs, P. E. B. (1999) · Australian and New Zealand Journal of Ophthalmology · doi:10.1046/j.1440-1606.1999.00238.x · Cited by 245
CHIN, H.-S., PARK, T.-S., MOON, Y.-S., & OH, J.-H. (2005) · Retina · doi:10.1097/00006982-200507000-00002 · Cited by 242
Compounds active against cell walls of medically important fungi
Hector, R. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.1 · Cited by 242
Saishin, Y., Saishin, Y., Takahashi, K., Silva, R. L. E., Hylton, D., Rudge, J. S., Wiegand, S. J., & Campochiaro, P. A. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10246 · Cited by 239
ENDOPHTHALMITIS: A Review of Current Evaluation and Management
LEMLEY, C. A., & HAN, D. P. (2007) · Retina · doi:10.1097/iae.0b013e3180323f96 · Cited by 239
Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future
De Clercq, E. (2004) · Chemistry & Biodiversity · doi:10.1002/cbdv.200490012 · Cited by 238
Sanborn, G. E. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140044023 · Cited by 230
Infliximab for Recurrent, Sight-Threatening Ocular Inflammation in Adamantiades–Behçet Disease
Sfikakis, P. P., Kaklamanis, P. H., Elezoglou, A., Katsilambros, N., Theodossiadis, P. G., Papaefthimiou, S., & Markomichelakis, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00025 · Cited by 229
Brown, D. M., & Regillo, C. D. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.039 · Cited by 224
Snoeck, R., Sakuma, T., De Clercq, E., Rosenberg, I., & Holy, A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.12.1839 · Cited by 223
ROSENFELD, P., SCHWARTZ, S., BLUMENKRANZ, M., MILLER, J., HALLER, J., REIMANN, J., GREENE, W., & SHAMS, N. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.01.043 · Cited by 223
Outcome of Intravitreal Triamcinolone in Uveitis
Kok, H., Lau, C., Maycock, N., McCluskey, P., & Lightman, S. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.06.009 · Cited by 221
Fluorouracil for the Treatment of Massive Periretinal Proliferation
Blumenkranz, M. S., Ophir, A., Claflin, A. J., & Hajek, A. (1982) · American Journal of Ophthalmology · doi:10.1016/0002-9394(82)90239-2 · Cited by 220
Park, C. H., Jaffe, G. J., & Fekrat, S. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00228-9 · Cited by 219
Spaide, R. F., Sorenson, J., & Maranan, L. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.08.012 · Cited by 219
Apt, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030584025 · Cited by 218
Sivalingam, A. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070080113046 · Cited by 218
Hida, T., Chandler, D., Arena, J. E., & Machemer, R. (1986) · American Journal of Ophthalmology · doi:10.1016/0002-9394(86)90593-3 · Cited by 217
Intravitreal Injection of Dexamethasone: Treatment of Experimentally Induced Endophthalmitis
Graham, R. O. (1974) · Archives of Ophthalmology · doi:10.1001/archopht.1974.01010010155016 · Cited by 217
Intravitreal Methotrexate as an Adjunctive Treatment of Intraocular Lymphoma
Fishburne, B. C. (1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100160322009 · Cited by 217
Tumour necrosis factor α inhibitors in the treatment of childhood uveitis
Saurenmann, R. K., Levin, A. V., Rose, J. B., Parker, S., Rabinovitch, T., Tyrrell, P. N., Feldman, B. M., Laxer, R. M., Schneider, R., & Silverman, E. D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel030 · Cited by 216
INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
FINTAK, D. R., SHAH, G. K., BLINDER, K. J., REGILLO, C. D., POLLACK, J., HEIER, J. S., HOLLANDS, H., & SHARMA, S. (2008) · Retina · doi:10.1097/iae.0b013e3181884fd2 · Cited by 214
Neovascular Age-Related Macular Degeneration: Potential Therapies
Chappelow, A. V., & Kaiser, P. K. (2008) · Drugs · doi:10.2165/00003495-200868080-00002 · Cited by 213
Efficacy of Etanercept in Preventing Relapse of Uveitis Controlled by Methotrexate
Foster, C. S. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.4.437 · Cited by 213
Inhibition of Intraocular Proliferations with Intravitreal Corticosteriods
Tano, Y., Sugita, G., Abrams, G., & Machemer, R. (1980) · American Journal of Ophthalmology · doi:10.1016/0002-9394(80)90239-1 · Cited by 213
Pseudophakic retinal detachment
Lois, N., & Wong, D. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00083-3 · Cited by 211
Favorable Response to High-Dose Infliximab for Refractory Childhood Uveitis
Kahn, P., Weiss, M., Imundo, L. F., & Levy, D. M. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.01.005 · Cited by 210
Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema
Conway, M. D., Canakis, C., Livir-Rallatos, C., & Peyman, G. A. (2003) · Journal of Cataract and Refractive Surgery · doi:10.1016/s0886-3350(02)01441-4 · Cited by 206
Self-citationSystemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration
Moshfeghi, A. A., Rosenfeld, P. J., Puliafito, C. A., Michels, S., Marcus, E. N., Lenchus, J. D., & Venkatraman, A. S. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.070 · Cited by 205
Cappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205
Selection of Therapeutic Agents for Intraocular Proliferative Disease: Cell Culture Evaluation
Blumenkranz, M. S. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030470029 · Cited by 204
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis
Savani, D. V., Perfect, J. R., Cobo, L. M., & Durack, D. T. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.1.6 · Cited by 202
Bodey, G. P. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.supplement_1.s161 · Cited by 199
5-fluorouracil: New Applications in Complicated Retinal Detachment for an Established Antimetabolite
Blumenkranz, M., Hernandez, E., Ophir, A., & Norton, E. W. D. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34318-4 · Cited by 197
Henry, K., Cantrill, H., Fletcher, C., Chinnock, B. J., & Balfour, H. H. (1987) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)74163-7 · Cited by 196
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin
Breit, S. M., Hariprasad, S. M., Mieler, W. F., Shah, G. K., Mills, M. D., & Grand, M. G. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.08.077 · Cited by 193
AUGUSTIN, A. J., PULS, S., & OFFERMANN, I. (2007) · Retina · doi:10.1097/iae.0b013e3180323de7 · Cited by 193
Microtubules in Transcellular Movement of Procollagen
EHRLICH, H. P., & BORNSTEIN, P. (1972) · Nature New Biology · doi:10.1038/newbio238257a0 · Cited by 193
Isenberg, S. J. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050090092039 · Cited by 192
Fibroblast growth factor stimulates photoreceptor differentiation in vitro
Hicks, D., & Courtois, Y. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-06-02022.1992 · Cited by 192
Ishibashi, T., Miki, K., Sorgente, N., Patterson, R., & Ryan, S. J. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050050100026 · Cited by 190
Rosenfeld, P. J., Heier, J. S., Hantsbarger, G., & Shams, N. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.01.027 · Cited by 189
Tumor necrosis factor α blockade with infliximab for refractory uveitis and scleritis
Murphy, C. C., Ayliffe, W. H., Booth, A., Makanjuola, D., Andrews, P. A., & Jayne, D. (2004) · Ophthalmology · doi:10.1016/s0161-6420(03)00721-8 · Cited by 188
Ip, M. S. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.8.1131 · Cited by 186
Intravitreal triamcinolone for refractory pseudophakic macular edema
Benhamou, N., Massin, P., Haouchine, B., Audren, F., Tadayoni, R., & Gaudric, A. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01938-4 · Cited by 183
Ciulla, T. A. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.3.399 · Cited by 182
Bjornsti, M.-A., & Houghton, P. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.027 · Cited by 181
Pai, S. A., Shetty, R., Vijayan, P. B., Venkatasubramaniam, G., Yadav, N. K., Shetty, B. K., Babu, R. B., & Narayana, K. M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.12.037 · Cited by 177
Complications of intravitreal injection of triamcinolone acetonide
Özkiriş, A., & Erkiliç, K. (2005) · Canadian Journal of Ophthalmology · doi:10.1016/s0008-4182(05)80119-x · Cited by 172
Liposomes in topical drug delivery.
Schaeffer, H. E., & Krohn, D. L. (1982) · PubMed · Cited by 170
Intraocular gas in the management of selected retinal detachments.
NORTON, E. W. D. (1973) · PubMed · Cited by 170
Etanercept and uveitis in patients with juvenile idiopathic arthritis
Schmeling, H., & Horneff, G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh658 · Cited by 169
Retrospective Case Review of Pediatric Patients with Uveitis Treated with Infliximab
RAJARAMAN, R., KIMURA, Y., LI, S., HAINES, K., & CHU, D. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.09.037 · Cited by 164
The Effect of Intravitreal Triamcinolone Acetonide on Intraocular Pressure
Bakri, S. J., & Beer, P. M. (2003) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20030901-08 · Cited by 164
Wickham, L., Bunce, C., Wong, D., McGurn, D., & Charteris, D. G. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.08.042 · Cited by 163
Spaide, R. F., Chang, L. K., Klancnik, J. M., Yannuzzi, L. A., Sorenson, J., Slakter, J. S., Freund, K. B., & Klein, R. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.08.016 · Cited by 162
Avitabile, T., Longo, A., & Reibaldi, A. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.05.021 · Cited by 161
Martidis, A., Duker, J. S., & Puliafito, C. A. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.9.1380 · Cited by 160
Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema
Jonas, J. B., Kreissig, I., & Degenring, R. F. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00230-7 · Cited by 160
Endogenous aspergillus endophthalmitis
Weishaar, P. D., Flynn, H. W., Murray, T. G., Davis, J. L., Barr, C. C., Gross, J. G., Mein, C. E., McLean, W. C., & Killian, J. H. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)71225-3 · Cited by 159
Intravitreal Sustained-Release Ganciclovir
Smith, T. J. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140111037 · Cited by 157
NGUYEN, Q., SHAH, S., Hafiz, G., Quinlan, E., SUNG, J., CHU, K., Cedarbaum, J. M., & Campochiaro, P. A. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.05.055 · Cited by 157
Infliximab for chronic cystoid macular edema associated with uveitis
Markomichelakis, N. N., THEODOSSIADIS, P. G., Pantelia, E., Papaefthimiou, S., THEODOSSIADIS, G. P., & Sfikakis, P. P. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.04.066 · Cited by 155
Ohm, J. (1911) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf01977971 · Cited by 153
Cataract Formation and Other Complications of Intravitreal Triamcinolone for Macular Edema
Thompson, J. T. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.11.050 · Cited by 153
Jacobson, M. A., O’Donnell, J. J., & MILLS, J. S. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.5.736 · Cited by 153
Mechanism of action of spiramycin and other macrolides
Brisson-Noël, A., Trieu‐Cuot, P., & Courvalin, P. M. (1988) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/22.supplement_b.13 · Cited by 149
Schliemann, C., Palumbo, A., Zuberbühler, K., Villa, A., Kaspar, M., Trachsel, E., Klapper, W., Menssen, H. D., & Neri, D. (2009) · Blood · doi:10.1182/blood-2008-05-160747 · Cited by 149
Intravitreal Ganciclovir in the Treatment of AIDS-associated Cytomegalovirus Retinitis
Ussery, F. M., Gibson, S. R., Conklin, R. H., Piot, D. F., Stool, E. W., & Conklin, A. J. (1988) · Ophthalmology · doi:10.1016/s0161-6420(88)33147-7 · Cited by 148
Long-term Intravitreal Ganciclovir Therapy for Cytomegalovirus Retinopathy
Heinemann, M. H. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020849025 · Cited by 147
Cardillo, J. A., Melo, L. A. S., Costa, R. A., Skaf, M., Belfort, R., Filho, A. A. D. S. L., Farah, M. E., & Kuppermann, B. D. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.03.023 · Cited by 147
Tornambe, P. E., Hilton, G. F., Brinton, D. A., Flood, T. P., Green, S. A., Grizzard, W. S., Hammer, M. E., Leff, S. R., Masciulli, L., Morgan, C. M., et al. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32168-7 · Cited by 144
Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.
Moritera, T., Ogura, Y., Honda, Y., Wada, R., Hyon, S., & Ikada, Y. (1991) · PubMed · Cited by 143
Ciardella, A. P. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.041707 · Cited by 143
Prophylaxis of Acute Posttraumatic Bacterial Endophthalmitis
Soheilian, M. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.460 · Cited by 139
Woods, A. C. (1950) · American Journal of Ophthalmology · doi:10.1016/0002-9394(50)91827-7 · Cited by 138
Cytomegalovirus Retinitis in Immunosuppressed Hosts
Pollard, R. B., Egbert, P. R., Gallagher, J., & Merigan, T. C. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-655 · Cited by 137
Benz, M. S., Murray, T. G., Dubovy, S. R., Katz, R., & Eifrig, C. W. G. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.2.271 · Cited by 135
Bonini-Filho, M. A., Jorge, R., Barbosa, J. C., Calucci, D., Cardillo, J. A., & Costa, R. A. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0297 · Cited by 132
Campochiaro, P. A., Jerdan, J. A., Glaser, B. M., Cardin, A., & Michels, R. G. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050090155053 · Cited by 131
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma
de Smet, M. D., Vancs, V. S., Köhler, D., Solomon, D., & Chan, C. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.4.448 · Cited by 130
Infliximab for juvenile idiopathic arthritis‐associated uveitis
Richards, J. C., Tay‐Kearney, M., Murray, K. J., & Manners, P. (2005) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2005.01062.x · Cited by 128
Jonas, J. B., Degenring, R. F., Kamppeter, B. A., Kreissig, I., & Akkoyun, İ. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.02.025 · Cited by 128
Ferguson, I., Schweitzer, J., & Johnson, E. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02176.1990 · Cited by 126
Early Bevacizumab Treatment of Central Retinal Vein Occlusion
Ferrara, D., Koizumi, H., & Spaide, R. F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.07.038 · Cited by 125
Development of Effective Ocular Preparations of Antifungal Agents
Kaur, I. P., Rana, C., & Singh, H. (2008) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0031 · Cited by 124
Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix.
Hageman, G. S., Kirchoff-Rempe, M. A., Lewis, G. P., Fisher, S. K., & Anderson, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6706 · Cited by 123
Kitzmann, A. S., Pulido, J. S., Mohney, B. G., Baratz, K. H., Grube, T., Marler, R. J., Donaldson, M. J., O’Neill, B. P., Johnston, P. B., Johnson, K. M., et al. (2007) · Eye · doi:10.1038/sj.eye.6702804 · Cited by 121
Rybak, M. J. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01342.x · Cited by 121
Bevacizumab in retinal vein occlusion-results of a prospective case series
Stahl, A., Agostini, H. T., Hansen, L. L., & Feltgen, N. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0569-6 · Cited by 121
Treatment of Acute Retinal Necrosis Syndrome with Oral Antiviral Medications
Aizman, A., Johnson, M. W., & Elner, S. G. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2006.06.058 · Cited by 121
Idoxuridine-Liposome Therapy for Herpes Simplex Keratitis
Smolin, G., Okumoto, M., Feiler, S., & Condon, D. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90177-x · Cited by 119
Epidemic Postsurgical Candida Parapsilosis Endophthalmitis
Stern, W. H., Tamura, E., Jacobs, R. A., Pons, V. G., Stone, R. D., O’Day, D. M., & Irvine, A. R. (1985) · Ophthalmology · doi:10.1016/s0161-6420(85)34095-2 · Cited by 117
Prevention and Management of Traumatic Endophthalmitis
Peyman, G. A., Carroll, C. P., & Raichand, M. (1980) · Ophthalmology · doi:10.1016/s0161-6420(80)35240-8 · Cited by 117
Self-citationShields, C. L., Demirci, H., DAI, V., Marr, B. P., Mashayekhi, A., Materin, M. A., Manquez, M. E., & Shields, J. A. (2005) · Retina · doi:10.1097/00006982-200510000-00009 · Cited by 117
Intravitreal Reinjection of Triamcinolone for Exudative Age-RelatedMacular Degeneration
Jonas, J. B. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.2.218 · Cited by 117
Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer.
Lopez‐Berestein, G., Kasi, L. P., Rosenblum, M. G., Haynie, T. P., Jahns, M. F., Glenn, H. J., Mehta, R. T., Mavligit, G. M., & Hersh, E. M. (1984) · PubMed · Cited by 117
Ip, M. S., & Kumar, K. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.9.1217 · Cited by 116
Slakter, J. S., Bochow, T. W., D’Amico, D. J., Marks, B. B., Jerdan, J. A., & Sullivan, E. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.019 · Cited by 116
Polak, A. (1987) · Chemotherapy · doi:10.1159/000238524 · Cited by 116
Bhavsar, A. R., Ip, M. S., & Glassman, A. R. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.04.011 · Cited by 113
Rosengren, B. (1938) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1938.tb06267.x · Cited by 112
Intraocular Injection of Gentamicin
May, D. R. (1974) · Archives of Ophthalmology · doi:10.1001/archopht.1974.03900060501015 · Cited by 111
Intravitreal Voriconazole: An Electroretinographic and Histopathologic Study
Gao, H., Pennesi, M. E., Shah, K. B., Qiao, X., Hariprasad, S. M., Mieler, W. F., Wu, S. M.-S., & Holz, E. R. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1687 · Cited by 110
Larsson, J., Zhu, M., Sutter, F., & Gillies, M. C. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.12.054 · Cited by 110
Augustin, A. J., & Schmidt-Erfurth, U. M. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.11.058 · Cited by 109
Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema
Moshfeghi, A. A., Scott, I. U., Flynn, H. W., & Puliafito, C. A. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.03.025 · Cited by 109
Research works printed but not linked: 9
- Komoto, 1912, Ueber Glaskorperwaschung bei unheilbarer Glaskorperblutung., KIin Monatsbl Augenheilkd, 50, 265
- Lowenstein, 1912, Uber Glaskorperersatz: 1.Teil: Experimentelle Untersuchungen., Albrecht von Graefes Arch Ophthalmol, 80, 500
- Zirm, 1925, Ein Beitrag zur Glaskorperabsaugung., Klin Monatsbl Augenheilkd, 75, 730
- Kucers, 1979, The Use of Antibiotics: A Comprehensive Review with Clinical Emphasis. 3rd ed.
- Smith, 2001, Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease., Arthritis Rheum, 45, 252, 10.1002/1529-0131(200106)45:3<252::aid-art257>3.0.co;2-5 · doi:10.1002/1529-0131(200106)45:3<252::aid-art257>3.0.co;2-5
- Rosenfeld, 2006, Ranibizumab: phase III clinical trial results., Ophthalmol Clin North Am, 19, 361
- Case, 1985, Clearance of intravitreal 3H-fluorouracil., Ophthalmic Surg, 16, 378
- Pillat, 1956, The aging of the retina., Trans Am Acad Ophthalmol Otolaryngol, 60, 206
- Dominguez, 1985, Cirugia precoz y ambulatoria del desprendimento de retina. (Spanish)., Arch Soc Esp Oftalmol, 48, 47
Cited by
Ocular drug delivery: present innovations and future challenges
Gote, V., Sikder, S., Sicotte, J., & Pal, D. (2019) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256933 · Cited by 441
“Novel ocular drug-delivery technologies such as nanoformulations, implants, and other ocular devices allow enhanced drug residence time at the target tissue along with improvements in pharmacological response (Peyman et al., 2009).”
BackgroundDrug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Suprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330
2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
Grzybowski, A., Told, R., Sacu, S., Bandello, F., Moisseiev, E., Loewenstein, A., Schmidt-Erfurth, U., & on behalf of the Euretina Board (2018) · Ophthalmologica · doi:10.1159/000486145 · Cited by 297
Complications of intravitreal injections
Sampat, K. M., & Garg, S. J. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328338679a · Cited by 287
Metadata
- Authors
- PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M.
- Affiliations
- University of Arizona (US)
- Stanford University (US)
- Corresponding author
- PEYMAN, GHOLAM A.
- Venue
- Retina
- Published
- 2009-07
- Volume
- 29
- Issue
- 7
- Pages
- 875-912
- ISSN
- 0275-004X (ISSN-L)
- OpenAlex
- W2090780299
- Cited by
- 255
- References
- 536
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 24 · 2023: 15 · 2022: 12 · 2021: 11 · 2020: 15 · 2019: 15 · 2018: 11 · 2017: 19 · 2016: 24 · 2015: 16 · 2014: 18 · 2013: 11 · 2012: 20
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Retina (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Keywords
- intravitreal injection, endophthalmitis, viral retinitis, age-related macular degeneration, cystoid macular edema, diabetic retinopathy, uveitis, retinal detachment, VEGF inhibitors, anti-inflammatory agents, immunomodulators, anticancer agents, gas tamponade, injection complications
- MeSH terms
- Drug Therapy, Humans, Injections, Vitreous Body
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.